| |
|
|
Daewoong Pharmaceutical (069620) |
|
|
STOCK |
|
|
|
  |
(Unit : 100Mn. Won) |
| Fiscal Year End |
2004. 3.31 | 2005. 3.31 | 2006. 3.31 | 2007. 3.31 | 2008. 3.31 |
| Cash & Cash Equivalents | 224.3 | 152.4 | 294.1 | 396.0 | 282.7 |
| Short-term Financial Instruments | 72.7 | 7.2 | 0.0 | 34.5 | 10.0 |
| Marketable securities | 0.0 | 147.8 | 102.2 | 114.2 | 85.7 |
| Account receivables | 556.0 | 491.3 | 669.4 | 780.6 | 911.4 |
| TOTAL QUICK ASSETS | 941.4 | 935.7 | 1,251.5 | 1,562.9 | 1,558.8 |
| TOTAL INVENTORY | 364.2 | 374.5 | 378.7 | 449.8 | 725.9 |
| TOTAL CURRENT ASSETS | 1,305.6 | 1,310.2 | 1,630.3 | 2,012.7 | 2,284.7 |
| TOTAL INVESTMENTS ASSETS | 211.7 | 186.5 | 180.7 | 258.0 | 273.5 |
| TOTAL TANGIBLE ASSETS | 738.8 | 793.3 | 804.7 | 860.5 | 1,125.2 |
| TOTAL INTANGIBLE ASSETS | 52.0 | 72.3 | 62.8 | 49.0 | 37.4 |
| TOTAL OTHER NON-CURRENT ASSETS | 22.2 | 25.1 | 27.7 | 38.0 | 147.7 |
| TOTAL NON-CURRENT ASSETS | 1,024.9 | 1,077.3 | 1,076.1 | 1,205.6 | 1,583.9 |
| TOTAL ASSETS | 2,330.5 | 2,387.6 | 2,706.4 | 3,218.4 | 3,868.7 |
| Trade account payable | 119.0 | 162.4 | 246.3 | 327.3 | 392.7 |
| Short-term borrowings | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Current portion of long-term liabilities | 204.9 | 4.8 | 0.0 | 199.7 | 0.0 |
| TOTAL CURRENT LIABILITIES | 764.1 | 561.2 | 617.0 | 1,012.7 | 854.6 |
| Total bonds | 0.0 | 199.0 | 199.3 | 0.0 | 296.0 |
| Long-term borrowings | 7.0 | 2.1 | 0.0 | 0.0 | 0.0 |
| TOTAL NON-CURRENT LIABILITIES | 111.7 | 301.1 | 324.2 | 80.8 | 376.8 |
| TOTAL LIABILITIES | 875.9 | 862.3 | 941.3 | 1,093.5 | 1,231.5 |
| Capital stocks | 246.9 | 246.9 | 246.9 | 246.9 | 246.9 |
| Capital surplus | 1,046.2 | 1,046.2 | 1,046.4 | 1,046.4 | 1,046.9 |
| Retained Earnings(Deficit) | 179.7 | 345.3 | 603.7 | 1,023.9 | 1,540.8 |
| TOTAL STOCKHOLDERS EQUITY | 1,454.6 | 1,525.2 | 1,765.1 | 2,124.9 | 2,637.2 |
|
 |
(Unit : 100Mn. Won) |
| Fiscal Year End |
2004. 3.31 | 2005. 3.31 | 2006. 3.31 | 2007. 3.31 | 2008. 3.31 |
| SALES(NET) | 2,484.1 | 2,803.9 | 3,381.6 | 4,004.4 | 4,842.4 |
| Cost of Sales | 1,134.9 | 1,327.5 | 1,606.7 | 1,795.6 | 2,239.6 |
| GROSS PROFIT | 1,349.2 | 1,476.4 | 1,774.9 | 2,208.7 | 2,602.8 |
| Seling & General Admin. Expenses | 1,003.1 | 1,133.9 | 1,263.8 | 1,505.9 | 1,860.3 |
| OPERATING INCOME | 346.0 | 342.4 | 511.0 | 702.8 | 742.4 |
| NON-OPERATING INCOME | 47.9 | 91.2 | 96.1 | 84.7 | 152.8 |
| Gain on valuation using equity method of accounting | - | - | 2.3 | 4.5 | 6.6 |
| NON-OPERATING EXPENSES | 170.2 | 69.7 | 117.7 | 110.5 | 98.0 |
| Loss on valuation using equity method of accounting | 18.0 | 0.8 | - | 0.8 | 1.0 |
| Ongoing Business Income(Loss) Before Income Taxes Expenses | 223.7 | 363.9 | 489.4 | 677.1 | 797.3 |
| Income Taxes Expenses for Ongoing Business Income or Loss | 75.4 | 105.2 | 137.1 | 191.8 | 207.4 |
| ONGOING BUSINESS INCOME(LOSS) | 148.2 | 258.7 | 352.3 | 485.2 | 589.8 |
| DISCONTINUED OPERATION INCOME(LOSS) | - | - | - | - | - |
| NET INCOME | 148.2 | 258.7 | 352.3 | 485.2 | 589.8 |
|
 |
(Unit : 100Mn. Won) |
| Fiscal Year End |
2004. 3.31 | 2005. 3.31 | 2006. 3.31 | 2007. 3.31 | 2008. 3.31 |
| Cash flows from operating activities |
297.1 | 302.2 | 293.6 | 489.6 | 264.0 |
| Add.of Cost without outflow of Cash |
176.5 | 130.9 | 176.1 | 201.0 | 265.5 |
| Depreciation |
48.2 | 61.9 | 73.0 | 78.1 | 78.1 |
| Deduc.of Rev.without inflow of Cash |
10.9 | 13.8 | 19.4 | 21.1 | 23.0 |
| Loss on Disposition of Invest.Assets |
9.4 | 36.7 | 22.1 | 17.5 | 83.2 |
| Changes in Ass. & Liab. resulting from operating Activities |
- 18.2 | - 50.7 | - 212.6 | - 179.1 | - 508.0 |
| Cash flows from investing activities |
- 169.5 | - 304.2 | - 22.5 | - 267.6 | - 386.0 |
| Inflow of cash |
44.0 | 132.7 | 230.8 | 154.7 | 244.4 |
| Outflow of cash |
213.5 | 436.9 | 253.4 | 422.4 | 630.5 |
| Cash flows from financing activities |
- 56.2 | - 69.9 | - 129.4 | - 120.0 | 8.6 |
| Inflow of cash |
- | 198.9 | - | - | 281.6 |
| Outflow of cash |
56.2 | 268.8 | 129.4 | 120.0 | 272.9 |
| Increase in Cash |
71.3 | - 71.9 | 141.6 | 101.9 | - 113.3 |
|
|
|
|
